The buyout price (excluding the CVR) is a paltry 16% premium to yesterday’s close; the small premium may be the result of a leak that caused CNCE’s price to rise in recent weeks. The nominal deal value is $580M.
Sun Pharma (the buyer) is India’s largest drug company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.